Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | IDH2 |
Variant | D76fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | IDH2 D76fs results in a change in the amino acid sequence of the Idh2 protein beginning at aa 76 of 452, likely resulting in premature truncation of the functional protein (UniProt.org). Due to the loss of the substrate binding region and sites critical for catalysis (UniProt.org), D76fs is predicted to lead to a loss of Idh2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
IDH2 mutant IDH2 inact mut IDH2 D76fs |
Transcript | NM_002168.4 |
gDNA | chr15:g.(90090626_90090627) |
cDNA | c.(226_225) |
Protein | p.D76fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_002168.3 | chr15:g.(90090626_90090627) | c.(226_225) | p.D76fs | RefSeq | GRCh38/hg38 |
NM_002168.4 | chr15:g.(90090626_90090627) | c.(226_225) | p.D76fs | RefSeq | GRCh38/hg38 |
NM_002168 | chr15:g.(90090626_90090627) | c.(226_225) | p.D76fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
IDH2 D76fs | acute myeloid leukemia | sensitive | Venetoclax | Case Reports/Case Series | Actionable | In a Phase II trial, an acute myeloid leukemia patient harboring IDH2 D76fs demonstrated sensitivity to treatment with Venclexta (venetoclax), achieving a complete response with incomplete blood count recovery after 24 weeks (PMID: 27520294). | 27520294 |